These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 31220157)

  • 1. Intravenous delivery of granulocyte-macrophage colony stimulating factor impairs survival in lipopolysaccharide-induced sepsis.
    Krebs J; Hillenbrand A; Tsagogiorgas C; Patry C; Tönshoff B; Yard B; Beck G; Rafat N
    PLoS One; 2019; 14(6):e0218602. PubMed ID: 31220157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Granulocyte-macrophage colony-stimulating factor and IFN-gamma restore the systemic TNF-alpha response to endotoxin in lipopolysaccharide-desensitized mice.
    Bundschuh DS; Barsig J; Hartung T; Randow F; Döcke WD; Volk HD; Wendel A
    J Immunol; 1997 Mar; 158(6):2862-71. PubMed ID: 9058823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Granulocyte-macrophage colony-stimulating factor, but not macrophage colony-stimulating factor, suppresses basal and lipopolysaccharide-stimulated complement factor production in human monocytes.
    Høgåsen AK; Hestdal K; Abrahamsen TG
    J Immunol; 1993 Sep; 151(6):3215-24. PubMed ID: 7690797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potentiation by granulocyte macrophage colony-stimulating factor of lipopolysaccharide toxicity in mice.
    Tiegs G; Barsig J; Matiba B; Uhlig S; Wendel A
    J Clin Invest; 1994 Jun; 93(6):2616-22. PubMed ID: 8201000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
    Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
    Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) secretion by adherent monocytes measured by quantitative immunoassays.
    Sallerfors B; Olofsson T
    Eur J Haematol; 1992 Oct; 49(4):199-207. PubMed ID: 1281454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro prevention and reversal of lipopolysaccharide desensitization by IFN-gamma, IL-12, and granulocyte-macrophage colony-stimulating factor.
    Randow F; Döcke WD; Bundschuh DS; Hartung T; Wendel A; Volk HD
    J Immunol; 1997 Mar; 158(6):2911-8. PubMed ID: 9058829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients.
    Rosenbloom AJ; Linden PK; Dorrance A; Penkosky N; Cohen-Melamed MH; Pinsky MR
    Chest; 2005 Jun; 127(6):2139-50. PubMed ID: 15947332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Granulocyte-macrophage colony-stimulating factor regulates cytokine production in cultured macrophages through CD14-dependent and -independent mechanisms.
    Bergamini A; Bolacchi F; Bongiovanni B; Cepparulo M; Ventura L; Capozzi M; Sarrecchia C; Rocchi G
    Immunology; 2000 Oct; 101(2):254-61. PubMed ID: 11012779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of three cytokine regimens after high-dose cyclophosphamide: granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor (GM-CSF), and sequential interleukin-3 and GM-CSF.
    Ballestrero A; Ferrando F; Garuti A; Basta P; Gonella R; Stura P; Mela GS; Sessarego M; Gobbi M; Patrone F
    J Clin Oncol; 1999 Apr; 17(4):1296. PubMed ID: 10561192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Granulocyte-macrophage colony-stimulating factor amplifies lipopolysaccharide-induced bronchoconstriction by a neutrophil- and cyclooxygenase 2-dependent mechanism.
    Wollin L; Uhlig S; Nüsing R; Wendel A
    Am J Respir Crit Care Med; 2001 Feb; 163(2):443-50. PubMed ID: 11179120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of continuous infusion granulocyte-macrophage colony-stimulating factor alone or followed by granulocyte colony-stimulating factor to enhance engraftment following high-dose chemotherapy and autologous bone marrow transplantation for lymphoid malignancies.
    Vose JM; Bierman PJ; Ruby E; Reed EC; Bishop MR; Tarantolo S; Kessinger A; Armitage JO
    Bone Marrow Transplant; 1996 Jun; 17(6):951-6. PubMed ID: 8807099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of granulocyte/macrophage colony-stimulating factor release from human monocytes by cyclic AMP-elevating drugs: role of interleukin-10.
    Seldon PM; Giembycz MA
    Br J Pharmacol; 2001 Sep; 134(1):58-67. PubMed ID: 11522597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Granulocyte-macrophage colony-stimulating factor modulates lipopolysaccharide (LPS)-binding and LPS-response of human macrophages: inverse regulation of tumour necrosis factor-alpha and interleukin-10.
    Kreutz M; Hennemann B; Ackermann U; Grage-Griebenow E; Krause SW; Andreesen R
    Immunology; 1999 Dec; 98(4):491-6. PubMed ID: 10594679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Toll-like receptor 4-activated neuroprotective microglia subpopulation survives via granulocyte macrophage colony-stimulating factor and JAK2/STAT5 signaling.
    Kamigaki M; Hide I; Yanase Y; Shiraki H; Harada K; Tanaka Y; Seki T; Shirafuji T; Tanaka S; Hide M; Sakai N
    Neurochem Int; 2016 Feb; 93():82-94. PubMed ID: 26802935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An mRNA atlas of G protein-coupled receptor expression during primary human monocyte/macrophage differentiation and lipopolysaccharide-mediated activation identifies targetable candidate regulators of inflammation.
    Hohenhaus DM; Schaale K; Le Cao KA; Seow V; Iyer A; Fairlie DP; Sweet MJ
    Immunobiology; 2013 Nov; 218(11):1345-53. PubMed ID: 23948647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of bronchoalveolar macrophage proinflammatory cytokine production by dexamethasone and granulocyte-macrophage colony-stimulating factor after stimulation by Aspergillus conidia or lipopolysaccharide.
    Kamberi M; Brummer E; Stevens DA
    Cytokine; 2002 Jul; 19(1):14-20. PubMed ID: 12200108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased tolerance to endotoxin by granulocyte-macrophage colony-stimulating factor-deficient mice.
    Basu S; Dunn AR; Marino MW; Savoia H; Hodgson G; Lieschke GJ; Cebon J
    J Immunol; 1997 Aug; 159(3):1412-7. PubMed ID: 9233638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.